Peter A Mcclennen Net Worth

The estimated Net Worth of Peter A Mcclennen is at least $1.95 millió dollars as of 28 June 2019. Peter Mcclennen owns over 18,924 units of Teladoc Health Inc stock worth over $86,709 and over the last 7 years Peter sold TDOC stock worth over $1,861,094.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Peter Mcclennen TDOC stock SEC Form 4 insiders trading

Peter has made over 7 trades of the Teladoc Health Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Peter sold 9,670 units of TDOC stock worth $676,900 on 10 July 2019.

The largest trade Peter's ever made was selling 27,533 units of Teladoc Health Inc stock on 7 March 2018 worth over $1,184,194. On average, Peter trades about 8,116 units every 38 days since 2017. As of 28 June 2019 Peter still owns at least 11,878 units of Teladoc Health Inc stock.

You can see the complete history of Peter Mcclennen stock trades at the bottom of the page.

What's Peter Mcclennen's mailing address?

Peter's mailing address filed with the SEC is C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE, NY, 10577.

Insiders trading at Teladoc Health Inc

Over the last 9 years, insiders at Teladoc Health Inc have traded over $190,385,368 worth of Teladoc Health Inc stock and bought 50,333 units worth $544,816 . The most active insiders traders include Hemant Taneja, Glen Tullman és Jason N Gorevic. On average, Teladoc Health Inc executives and independent directors trade stock every 6 days with the average trade being worth of $111,413. The most recent stock trade was executed by Andrew Turitz on 4 September 2024, trading 20,773 units of TDOC stock currently worth $150,812.

What does Teladoc Health Inc do?

Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Ranked best in KLAS for Virtual Care Platforms in 2020, Teladoc Health leverages more than a decade of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals.

Complete history of Peter Mcclennen stock trades at Teladoc Health Inc

Teladoc Health Inc executives and stock owners

Teladoc Health Inc executives and other stock owners filed with the SEC include:

• Jason Gorevic,
  Chief Executive Officer, Director
• David Sides,
  Chief Operating Officer
• Mala Murthy,
  Chief Financial Officer
• Lewis Levy,
  Chief Medical Officer
• Stephanie Verstraete,
  Chief Marketing Officer
• Adam Vandervoort,
  Chief Legal Officer and Secretary
• Jason Nathanial Gorevic,
  CEO & Director
• Claus Torp Jensen Ph.D.,
  Chief Innovation Officer
• Mala Murthy,
  Chief Financial Officer
• Adam Christian Vandervoort,
  Chief Legal Officer & Sec.
• Gabriel Cappucci,
  Senior Vice President - Finance
• David Snow,
  Independent Chairman of the Board
• David Shedlarz,
  Independent Director
• Thomas McKinley,
  Independent Director
• William Frist,
  Independent Director
• Kenneth Paulus,
  Independent Director
• Mark Smith,
  Independent Director
• Catherine Jacobson,
  Independent Director
• Andrew Turitz,
  Senior Vice President of Business Development
• Michelle Bucaria,
  Chief Human Resource Officer
• Mike Waters,
  Chief Operating Officer
• Arnnon Geshuri,
  Chief HR Officer
• Andrew Turitz,
  Sr. VP of Corp. Devel.
• Courtney Kraemer McLeod,
  Director of Communication
• Patrick Thomas Feeley C.F.A., CPA,
  VP of Investor Relations
• Richard J. Napolitano,
  Sr. VP, Chief Accounting Officer & Controller
• Dr. George Byron Brooks,
  Co-Founder
• Stephany Verstraete,
  Chief Marketing Officer & Engagement Officer
• James L. Cave,
  INTERIM CAO
• Tom Mawhinney,
  Director
• Arneek Multani,
  Director
• Iii Lp Chp,
  10% owner
• Iii Lpchp Iii Management, L...,
  
• James K Outland,
  Director
• Martin R Felsenthal,
  Director
• Michael Goldstein,
  Director
• Michael H. King,
  Chief Sales Officer
• Peter N. Nieves,
  EVP and CRO
• Capital Management Vi, L.L....,
  
• Helen Darling,
  Director
• Iii Management, L.L.C. Chp,
  10% owner
• Dana G Jr. Mead,
  Director
• Arnnon Geshuri,
  CHIEF PEOPLE OFFICER
• Brian P Mcandrews,
  Director
• Mark Hirschhorn,
  Executive VP and CFO
• Peter A Mcclennen,
  President
• Venture Partners Ii, L.P.Hl...,
  
• Karen L Daniel,
  Director
• Dgf Associates, Llckpcb Dig...,
  
• Vidya Raman Tangella,
  CHIEF MEDICAL OFFICER
• Laizer Kornwasser,
  Advisor to the CEO
• Christopher Caridi,
  Chief Accounting Officer
• Richard J Napolitano,
  CHIEF ACCOUNTING OFFICER
• Yulun Wang,
  Head of Research & Development
• Hemant Taneja,
  Director
• Glen Tullman,
  Director
• Christopher Bischoff,
  
• Jason Eric Evans,
  Director
• Claus Torp Jensen,
  CHIEF INNOVATION OFFICER
• Daniel Trencher,
  CHIEF STRATEGY OFFICER
• Stephany Verstraete,
  CHIEF MARKETING OFFICER
• Michael Willem Waters,
  CHIEF OPERATING OFFICER
• Nikolaos P. Nanis,
  Chief Technology Officer
• Sandra L Fenwick,
  Director
• Charles Iii Divita,
  CHIEF EXECUTIVE OFFICER